John P. Leonard, Marek Trneny, Huilai Zhang, Grzegorz S. Nowakowski, Koji Izutsu, Nathan Fowler, Catherine Thieblemont, Pier Luigi Zinzani, Argyrios Gkasiamis, Jung Ryun Ahn, John G. Gribben. "Lenalidomide Plus Rituximab for Relapsed/Refractory Indolent Non-Hodgkin Lymphoma: 5-Year Follow-Up and Subgroup Analyses From the Phase III AUGMENT Trial." Journal of Clinical Oncology, 2026. doi:10.1200/jco-25-01770